Low molecular weight (LMW) orally bioavailable inhibitors of tumor vascular endothelial growth factor (VEGF) translation delay tumor growth in vivo: A new approach to inhibition of angiogenesis

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3123-3123
Author(s):  
M. Weetall ◽  
L. Cao ◽  
Y. C. Moon ◽  
T. Davis ◽  
S. Hirawat ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Vascular Endothelial Growth Factor ◽  
Low Molecular Weight ◽  
Vascular Endothelial ◽  
Delay Tumor Growth ◽  
New Approach ◽  
Inhibition Of Angiogenesis ◽  
Orally Bioavailable ◽  
Endothelial Growth Factor

scholarly journals Use of Proximity Ligation to Screen for Inhibitors of Interactions between Vascular Endothelial Growth Factor A and Its Receptors

2008 ◽  
Vol 54 (7) ◽  
pp. 1218-1225 ◽  
Author(s):  
Sigrun M Gustafsdottir ◽  
Stefan Wennström ◽  
Simon Fredriksson ◽  
Edith Schallmeiner ◽  
Andrew D Hamilton ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Dose Response ◽  
Dna Aptamer ◽  
Low Molecular Weight ◽  
Vascular Endothelial ◽  
Proximity Ligation ◽  
Receptor Complexes ◽  
Endothelial Growth Factor

Abstract Background: Improved methods are required to screen drug candidates for their influences on protein interactions. There is also a compelling need for miniaturization of screening assays, with attendant reductions in reagent consumption and assay costs. Methods: We used sensitive, miniaturized proximity ligation assays (PLAs) to monitor binding of vascular endothelial growth factor A (VEGF-A) to 2 of its receptors, VEGFR-1 and VEGFR-2. We measured the effects of proteins and low molecular weight compounds capable of disrupting these interactions and compared the results with those obtained by immunoblot analysis. We analyzed 6 different inhibitors: a DNA aptamer, a mixed DNA/RNA aptamer, a monoclonal VEGF-A neutralizing antibody, a monoclonal antibody directed against VEGFR-2, a recombinant competitive protein, and a low molecular weight synthetic molecule. Results: The PLAs were successful for monitoring the formation and inhibition of VEGF-A–receptor complexes, and the results correlated well with those obtained by measuring receptor phosphorylation. The total PLA time is just 3 hours, with minimal manual work and reagent additions. The method allows evaluation of the apparent affinity [half-maximal inhibitory concentration (IC50)] from a dose–response curve. Conclusions: The PLA may offer significant advantages over conventional methods for screening the interactions of ligands with their receptors. The assay may prove useful for parallel analyses of large numbers of samples in the screening of inhibitor libraries for promising agents. The technique provides dose–response curves, allowing IC50 values to be calculated.

scholarly journals Role of vascular endothelial growth factor in inducing production of angiopoetin-1 – in vivo study in Fisher rats

2017 ◽  
Vol 68 (4) ◽  
pp. 326-329
Author(s):  
Piotr Barć ◽  
Tomasz Płonek ◽  
Dagmara Baczyńska ◽  
Artur Pupka ◽  
Wojciech Witkiewicz ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
In Vivo Study ◽  
Vascular Endothelial ◽  
Angiopoetin 1 ◽  
Endothelial Growth Factor
Sign in / Sign up

Export Citation Format

Share Document